Article
Molecular pathology and clinical treatment of primary serous carcinoma of the uterine cervix: A case report
2022-11-16
Abstract excerpt
A 69 years old Chinese female patient presented with independent HPV serous carcinoma uterine cervix. The genetic testing identified gene variants of PAX8 and TP53, microsatellite instability stable, TMB 7.33Muts/Mb. The patient had a good response to Docetaxel, carboplatin, and radiation with 18 months of free disease survival.
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 441ecd8d-3e9d-53e0-985e-b8060c91e91c
- DOI
- 10.22541/au.166861809.97469909/v1
